Filings

2 documents · 2 matches

1. IART INTEGRA LIFESCIENCES HOLDINGS CORP 10-K 2026-02-26

   Item 16. Form 10-K Summary

   material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk
   1 match in this document Show context Copy citation

2. IART INTEGRA LIFESCIENCES HOLDINGS CORP 10-Q 2026-10-23

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   materials for temporary reinforcement) across our soft tissue solutions portfolio. These technologies include devices for implantation to reinforce soft tissue where weakness
   1 match in this document Show context Copy citation